BeStock  
Stocks › Drug Manufacturers - Specialty & Generic › TEVA

Teva Pharmaceutical Industries TEVA

US equityMarket cap rank #332Drug Manufacturers - Specialty & GenericInfectious DiseaseCannabis & Hemp
$39.22 −$0.39 (-0.97%)
Market open · Oct 1, 12:40 pm ET · After hours $39.60 0.00%
Open$39.48
Prev close$39.60
Day range$38.53 – $39.54
Volume1.83M
Market cap$45.74B
P/E (TTM)65.4
Dividend yield–

TEVA Stock News

Headlines matching Teva Pharmaceutical Industries or the TEVA ticker, most recent first.

  • Leerink Partners Initiates Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $45Market news · 9 Sep 2026
  • UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $48Market news · 4 Sep 2026
  • Goldman Sachs Initiates Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $50Market news · 3 Sep 2026
  • Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $40Market news · 3 Sep 2026
  • Evercore Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy RatingMarket news · 3 Sep 2026
  • Scotiabank Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $40Market news · 3 Sep 2026
  • J.P. Morgan Sticks to Their Buy Rating for Teva (TEVA)TipRanks · 25 Sep 2026
  • J.P. Morgan Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy RatingMarket news · 25 Sep 2026
  • BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $43Market news · 24 Sep 2026
  • Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 A.m. ETGlobeNewswire · 24 Sep 2026
  • Teva Pharmaceutical Industries(TEVA.US) Director Sells US$14.36 Million in Common StockMarket news · 23 Sep 2026
  • Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia CareGlobeNewswire · 16 Sep 2026
  • UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $42Market news · 7 Aug 2026
  • Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $44Market news · 27 Aug 2026
  • Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $42Market news · 12 Aug 2026

Discussion

No comments yet — be the first to weigh in on TEVA.

Leave a comment

Scroll to Top